Sort by
Innovative Research on Identifying the Potential Association between Emotional Abnormalities and Physiological Illnesses in Young Children: Construction of an Artificial Intelligence-Based Recognition Model
Chia-Chen Tseng
Posted: 05 December 2025
From Thermal Springs to Saline Solutions: A Scoping Review of Salt-Based Oral Healthcare Interventions
Elisabetta Ferrara
,Manela Scaramuzzino
,Biagio Rapone
,Giovanna Murmura
,Bruna Sinjari
Posted: 01 December 2025
“I Know That Clinic Isn’t Meant for Me”: Barriers to Primary Health Care for Adults with Physical Disabilities in Rural Ethiopia—A Critical Disability Theory Perspective
Addisu Taye Abate
,Lenora Duhn
,Rosemary Wilson
,Pilar Camargo-Plazas
Posted: 28 November 2025
A Cross-Sectional Study on Mothers’ Knowledge, Attitudes, and Practices Towards Nutrition of Malnourished Under-Five Children in a Kabul City Hospital, Afghanistan
Husnia Hossainy
,Rohina Amel
,Rohullah Sakhi
Posted: 26 November 2025
How to Teach Healthy Life-Style Efficiently in a Pediatric Outpatient Setting: Proposal of an Innovative Tridimensional Pyramid
Angelika Mohn
,Giada Di Pietro
,Alessandro Maggitti
,Giulia Trisi
,Ilaria Bucci
,Martina Passarelli
,Nella Polidori
,Armando Di Ludovico
,Francesco Chiarelli
Posted: 26 November 2025
The Changing Landscape of Sodium Needs in the Preterm Neonate for Optimizing Growth and Development
Chrysoula Kosmeri
,Maria Baltogianni
,Niki Dermitzaki
,Chrysanthi Maria Tsiogka
,Vasileios Giapros
Posted: 24 November 2025
Sociodemographic and Geographic Influences of Mental Health Literacy: A Cross-Sectional Survey Among Community Health Clinic Attendees in Tshwane, South Africa
Oratilwe Penwell Mokoena
,Eric Maimela
,Dumisile Priscilla Madlala
,Sam Thembelihle Ntuli
Posted: 18 November 2025
The Triglyceride–Glucose (TyG) Index and Cardiovascular Diseases: A Narrative Review
Mumtaz Murat Yardimci
Posted: 10 November 2025
OM-to-Genome: A Low-Cost Vibrational Pathway to Stress and Inflammation Control for One Health
Rajnikant Dixit
Stress- and inflammation-related disorders remain the dominant global health burdens, yet few preventive tools operate across molecular, psychological, and social scales. We hypothesize that OM-induced vibrational coherence functions as a mathematical–cum-biophysical regulator capable of harmonizing energy from cellular metabolism to genomic expression through the vagal–microbiome–brain axis. Following the physical law that energy transforms but is conserved, the OM-to-Genome continuum extends this principle to living systems, where metabolic, immune, reproductive, and neural energies represent biological analogues of potential, chemical, and kinetic forms. Mathematics provides the syntax of these transformations—frequency, proportion, and rhythm—governing energy construction and deconstruction from birth to death. Within the author’s Evolution-to-Solution framework, OM vibration mediates these conversions, translating conscious intent into physiological order. Evidence from neuroimaging, electrophysiology, and molecular biology supports this pathway as a low-cost, culturally neutral mechanism for stress regulation and immune balance. Integrating mathematics, physics, chemistry, and physiology thus yields a unified One Health model linking awareness and biology through a single law of energy coherence.
Stress- and inflammation-related disorders remain the dominant global health burdens, yet few preventive tools operate across molecular, psychological, and social scales. We hypothesize that OM-induced vibrational coherence functions as a mathematical–cum-biophysical regulator capable of harmonizing energy from cellular metabolism to genomic expression through the vagal–microbiome–brain axis. Following the physical law that energy transforms but is conserved, the OM-to-Genome continuum extends this principle to living systems, where metabolic, immune, reproductive, and neural energies represent biological analogues of potential, chemical, and kinetic forms. Mathematics provides the syntax of these transformations—frequency, proportion, and rhythm—governing energy construction and deconstruction from birth to death. Within the author’s Evolution-to-Solution framework, OM vibration mediates these conversions, translating conscious intent into physiological order. Evidence from neuroimaging, electrophysiology, and molecular biology supports this pathway as a low-cost, culturally neutral mechanism for stress regulation and immune balance. Integrating mathematics, physics, chemistry, and physiology thus yields a unified One Health model linking awareness and biology through a single law of energy coherence.
Posted: 10 November 2025
The Clinical Significance of the Manchester Colour Wheel in a Sample of People Treated for Insured Injuries
John Edward McMahon
,Ashley Craig
,Ian Douglas Cameron
Posted: 06 November 2025
Butterworth Filtering at 500 Hz Optimizes PPG-Based Heart Rate Variability Analysis for Wearable Devices: A Comparative Study
Nagima Abdrasulova
,Milana Aleksanyan
,Min Ju Kim
,Jae Mok Ahn
Posted: 04 November 2025
Injectable Therapies and their Effects on the Modulation of Chronic Inflammation in Immunometabolic Diseases: Obesity, Cancer, and Type 2 Diabetes Mellitus
Esdras Couto
,Sodré GB Neto
Posted: 03 November 2025
A Scoping Review of Refugee Children’s Health Conditions, Outcomes and Measures Used in Refugee-Serving Public Health Centres/Clinics in Canada
Augustine Botwe
,Nour Armoush
,Cheryl Poth
,Sophie Yohani
,Rebecca Gokiert
Posted: 03 November 2025
Hippocampal-Sparing Whole-Brain Radiotherapy: Dosimetric Comparison of 3D-CRT, IMRT, and VMAT for Brain Metastases from Lung Cancer
Le Ba Thach
,Mai Thi Thao
,Nguyen Viet Nghia
,Tran Nhat My
,Duong Thanh Tai
,Nissren Tamam
,Abdelmoneim Sulieman
,Hiba Omer
,Hind Toufig
,David Bradley
Posted: 29 October 2025
Breast Cancer: Is the Current Screening Appropriate? The RISCAM Study
Maria Inês Leal
,Sónia Torres
,Ana Beatriz Silva
,Daniela Bento
,Deolinda Chaves Beça
,António Pereira
Background: Early diagnosis is key for improving outcomes of breast cancer cases. However, controversy remains regarding the lower age limits and non-personalized nature of screening programs. The main objectives of this study are to investigate the relevance of defining a new lower age limit for breast cancer screening, characterize risk factors not included in the Tyrer-Cuzick™ risk assessment calculator, and explore the feasibility of personalizing screening. Methods: This study is an observational case-control. The case group included 64 women with a breast cancer diagnosis. Breast cancer incidence by age group was obtained. Participants were characterized concerning cancer risk factors, namely smoking habits, alcohol consumption and breastfeeding. A risk score was attributed to each woman through the Tyrer-Cuzick™ risk model, and subsequent stratification into several risk groups was done. Finally, the relationship between intermediate to high-risk scores and breast cancer development was studied. Results: We found no statistically significant differences between breast cancer incidences in women between the ages of 40 and 49 vs. 50 to 69, in the Health Units under study. There was no statistically significant link between the studied risk factors and breast cancer development. We observed a statistically significant relationship between intermediate to high-risk scores and the development of breast cancer (OR 10.0 with p = 0.0009). Conclusion: These results support screening from the age of 40 and the applicability of a patient-centered model, given that the screening tool has high sensibility.
Background: Early diagnosis is key for improving outcomes of breast cancer cases. However, controversy remains regarding the lower age limits and non-personalized nature of screening programs. The main objectives of this study are to investigate the relevance of defining a new lower age limit for breast cancer screening, characterize risk factors not included in the Tyrer-Cuzick™ risk assessment calculator, and explore the feasibility of personalizing screening. Methods: This study is an observational case-control. The case group included 64 women with a breast cancer diagnosis. Breast cancer incidence by age group was obtained. Participants were characterized concerning cancer risk factors, namely smoking habits, alcohol consumption and breastfeeding. A risk score was attributed to each woman through the Tyrer-Cuzick™ risk model, and subsequent stratification into several risk groups was done. Finally, the relationship between intermediate to high-risk scores and breast cancer development was studied. Results: We found no statistically significant differences between breast cancer incidences in women between the ages of 40 and 49 vs. 50 to 69, in the Health Units under study. There was no statistically significant link between the studied risk factors and breast cancer development. We observed a statistically significant relationship between intermediate to high-risk scores and the development of breast cancer (OR 10.0 with p = 0.0009). Conclusion: These results support screening from the age of 40 and the applicability of a patient-centered model, given that the screening tool has high sensibility.
Posted: 29 October 2025
Human Cancers Deriving from Either Genetic or Lifestyle Factors, Are Initiated by the Damage of Estrogen Signaling
Zsuzsanna Suba
Posted: 28 October 2025
Evaluating AI Robotic/Robotic-Assisted Surgical Approaches vs. Traditional Surgical Approaches for Osteoarthritis: A Critical Review
Muhammad Adil Malik
,Song Wu
Posted: 27 October 2025
Determinants of Folate and Vitamin B₁₂ Deficiencies in Under-Five Children: Insights from the National Nutrition Survey of Pakistan
Junaid Iqbal
,Kehkashan Begum
,Rabia Zuberi
,Sajid Muhammad
,Shabina Ariff
,Imran Ahmed Chauhadry
,Sajid B. Soofi
,Zulfiqar A. Bhutta
Posted: 27 October 2025
Minority Estrogen in Systemic Lupus Erythematosus; The Door-to-Diagnosis Clock Ticketh
Anthara Vivek
,Mahesh Narayan
,Manisha Shukla
,Prakash Narayan
Posted: 27 October 2025
Angiography-Assisted Cone-Beam CT–Guided Radiofrequency Ablation for Hepatocellular Carcinoma: Single-Center Workflow and Early Outcomes
Jung Ui Hong
,Soon Gu Cho
,Kyu Hong Lee
,Ji Hoon Noh
,Ro Woon Lee
Background: Conventional CT- or US-guided radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) often limits repeat contrast-enhanced imaging and provides suboptimal intraprocedural conspicuity, which can hinder precise targeting and margin assessment. Purpose: To describe a single-center angiography-assisted cone-beam CT (angio-CBCT) RFA workflow and report early outcomes versus an institutional conventional CT–guided cohort. Materials and Methods: In this IRB-approved single-center retrospective study, consecutive patients underwent angio-CBCT–guided RFA for HCC (n=14). Selective intra-arterial injections (≈20–40 mL iodinated contrast per CBCT) through a 5-Fr catheter permitted multiple intraprocedural CBCT acquisitions for targeting, verification, and endpoint assessment under general anesthesia. Primary outcomes were technical success, early local recurrence, and complications (CTCAE v6.0). For a secondary imaging analysis, within-patient change in lesion conspicuity (ΔHU = HU_tumor − HU_liver) from preprocedural contrast-enhanced CT to intraprocedural imaging was compared in available cases (angio-CBCT n=12; conventional CT n=13). Descriptive statistics were used. Results: Angio-CBCT RFA achieved technical success in 14/14 (100%) procedures; early local recurrence was 0/14 (0.0%); and one complication occurred (1/14, 7.1%; Grade 3). Intraprocedural refinements included immediate re-ablation in 3/14 (21.4%) and electrode repositioning in 2/14 (14.3%), with on-table detection of an additional lesion in 1/14 (7.1%). In the institutional conventional cohort, technical success was 19/20 (95.0%), early local recurrence 2/20 (10.0%), and complications 0/20 (0%). Lesion conspicuity improved with angio-CBCT (median ΔHU 290.1 HU, n=12) but not with conventional CT (−10.5 HU, n=13). Conclusion: Angio-CBCT–guided RFA for HCC is feasible and safe and enables repeatable, low-volume contrast–enhanced intraprocedural imaging that supports precise targeting, verification, and timely refinements. Early outcomes and markedly improved lesion conspicuity suggest potential advantages over conventional CT–guided workflows and warrant prospective validation in larger cohorts.
Background: Conventional CT- or US-guided radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) often limits repeat contrast-enhanced imaging and provides suboptimal intraprocedural conspicuity, which can hinder precise targeting and margin assessment. Purpose: To describe a single-center angiography-assisted cone-beam CT (angio-CBCT) RFA workflow and report early outcomes versus an institutional conventional CT–guided cohort. Materials and Methods: In this IRB-approved single-center retrospective study, consecutive patients underwent angio-CBCT–guided RFA for HCC (n=14). Selective intra-arterial injections (≈20–40 mL iodinated contrast per CBCT) through a 5-Fr catheter permitted multiple intraprocedural CBCT acquisitions for targeting, verification, and endpoint assessment under general anesthesia. Primary outcomes were technical success, early local recurrence, and complications (CTCAE v6.0). For a secondary imaging analysis, within-patient change in lesion conspicuity (ΔHU = HU_tumor − HU_liver) from preprocedural contrast-enhanced CT to intraprocedural imaging was compared in available cases (angio-CBCT n=12; conventional CT n=13). Descriptive statistics were used. Results: Angio-CBCT RFA achieved technical success in 14/14 (100%) procedures; early local recurrence was 0/14 (0.0%); and one complication occurred (1/14, 7.1%; Grade 3). Intraprocedural refinements included immediate re-ablation in 3/14 (21.4%) and electrode repositioning in 2/14 (14.3%), with on-table detection of an additional lesion in 1/14 (7.1%). In the institutional conventional cohort, technical success was 19/20 (95.0%), early local recurrence 2/20 (10.0%), and complications 0/20 (0%). Lesion conspicuity improved with angio-CBCT (median ΔHU 290.1 HU, n=12) but not with conventional CT (−10.5 HU, n=13). Conclusion: Angio-CBCT–guided RFA for HCC is feasible and safe and enables repeatable, low-volume contrast–enhanced intraprocedural imaging that supports precise targeting, verification, and timely refinements. Early outcomes and markedly improved lesion conspicuity suggest potential advantages over conventional CT–guided workflows and warrant prospective validation in larger cohorts.
Posted: 23 October 2025
of 21